velagliflozin
a sodium-glucose cotransporter 2 (SGLT2) inhibitor for the treatment of diabetes
Also Known As:
2-((4-cyclopropylphenyl)methyl)-4-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)benzonitrile
Networked: 2
relevant articles (1 outcomes,
1 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Clark, M:
1 article
(04/2018)
|
2. | Hoenig, M:
1 article
(04/2018)
|
3. | Reiche, D:
1 article
(04/2018)
|
4. | Schaeffer, D J:
1 article
(04/2018)
|
5. | Meier, Alexandra:
1 article
(01/2018)
|
6. | Pollitt, Christopher:
1 article
(01/2018)
|
7. | Reiche, Dania:
1 article
(01/2018)
|
8. | Sillence, Martin:
1 article
(01/2018)
|
9. | Walsh, Donald:
1 article
(01/2018)
|
10. | de Laat, Melody:
1 article
(01/2018)
|
Related Diseases
Related Drugs and Biologics